Navigation Links
Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes'
Date:2/19/2008

NEW YORK, Feb. 19 /PRNewswire/ -- On November 5, 2007, under increasing government pressure, Bayer Pharmaceuticals Corporation said that it had halted worldwide sales of its drug Trasylol after a Canadian clinical study found the drug could be linked to a higher risk of death than other drugs. The Food and Drug Administration asked the company to stop selling the drug, used to prevent excessive bleeding during heart bypass surgery, pending detailed review of preliminary results from the Canadian study.

In the wake of Bayer's announcement that it was pulling its controversial heart surgery drug Trasylol from the market, nationally known plaintiff's advocates Napoli Bern & Associates, LLP commenced several litigations seeking damages for a heart patient's death. One of those litigations, arising from the death of Joseph Randone, was profiled by CBS's "60 Minutes" on Sunday, February 17, 2008. In that story, renowned medical researcher Dr. Dennis Mangano calculated that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago, when his study revealed widespread death associated with it. Dr. Mangano also told 60 Minutes correspondent Scott Pelley that Bayer, the drug's maker, failed to tell the FDA about negative results of their own Trasylol study and that the company's failure to fully apprise the FDA of their own study's findings placed the drug's success before patient well-being.

The Randone case (Josephine Randone, Executrix Of The Estate Of Joseph Randone, And Josephine Randone, Individually, v. Bayer Corporation, et al.) was filed by Napoli Bern & Associates, LLP, and arises from horrific post- surgical complications suffered by Joseph Randone, a 52-year-old man who suffered kidney failure leading to a chain reaction resulting in his death following routine valve replacement surgery where Trasylol was utilized. Attorney Marc Jay Bern says, "the importance of the Trasylol
'/>"/>

SOURCE Napoli Bern & Associates, LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. 60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
2. Trasylol Pulled From Worldwide Market
3. Bayer Temporarily Suspends Global Trasylol(R) Marketing
4. Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Have Been Filed Against American Dental Partners, Inc.
5. CryoCath Provides Update on Patent Infringement Lawsuit
6. More Women File Lawsuits Against Dallas Presbyterian Hospital in Eating Disorders Fraud Case
7. Abbey Spanier Rodd & Abrams, LLP Files Class Action Lawsuit on Behalf of Purchasers of American Dental Partners, Inc. Securities
8. Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit
9. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
10. The Willie Gary Law Firm Files $1 Billion Lawsuit Against Durham County LME, Wake County LME, Five County LME, Mecklenberg County LME and Value Options, Inc. for Negligent and Intentional Misconduct Against Mental Health Agency
11. Hollywood Presbyterian Medical Center Responds to ACLU Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... (PRWEB) December 22, 2014 Fad diets ... changed. The reason why most fad diets have hung ... The problem with fad diets is that, as the body ... the dieter uncertain of how to reset the metabolism to ... reason, Diet Doc developed their all-inclusive diet plans ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The founders ... BLS and ACLS online certification provider, are proud to ... . The updated site now features a more user-friendly ... ever to use. , As a company spokesperson ... is now consolidated into a single page during the ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 ... current Ebola virus epidemic are receiving further ... government agencies, nongovernmental organizations (NGOs) and other ... ongoing, healthcare workers, emergency responders, patients and ... such as the CmTP MediDefense system ...
(Date:12/22/2014)... Physicians in China are most eagerly ... of non-Hodgkin’s lymphoma (NHL), according to a new report ... consulting firm. MabThera is the only biologic available to ... form of NHL. , According to Kantar Health’s report, ... of NHL in China has been growing and is ...
(Date:12/22/2014)... OH (PRWEB) December 22, 2014 Explorys, ... three additions to its leadership team: Greg Yarrington as ... of Engineering, and Patrick Wells as Vice President of ... to add 80 new jobs in 2015 to support ... expansion of its platform-as-a-service offerings, and growth of its ...
Breaking Medicine News(10 mins):Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 2Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 3Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 4Health News:ACLS Online Certification Website ACLS-PALS-BLS.com Now Features a New and User-Friendly Layout 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3
... at Wake Forest University Baptist Medical Center (WFUBMC) have discovered ... breast cancer. For the first time, a peptide found in ... of human breast tumors in mice, according to a study ... Patricia E. Gallagher, Ph.D., and E. Ann Tallant, Ph.D., scientists ...
... Hydrocephalus in Ugandan children and other developing countries is ... by previous bacterial infection, according to an international team ... believe that the best approach to this problem is ... grand medical mystery," said Steven Schiff, the Brush Chair ...
... , THURSDAY, Dec. 30 (HealthDay News) -- Certain ... a new study finds. Because of increasing urbanization, ... more than ever before. For example, foxes, raccoons and ... mice, rats, birds and other prey. For this ...
... , , , , , ... , AUDIO: Its not news ... Click here for more information. , ... , , , , , ...
... -- Researchers report that they,ve gained insight into the workings ... in how the body stores fat to protect against future ... be linked to both insulin sensitivity and the survival of ... all these different phenomena," Dr. Philipp Scherer, a professor of ...
... Reporter , THURSDAY, Dec. 29 (HealthDay News) -- As fears ... gripped much of the United States the past two winters, George ... As vice president of human resources for a Fort Lauderdale commercial ... and protect not only the company,s employees but also the tenants ...
Cached Medicine News:Health News:Peptide delivers 1-2 punch to breast cancer in pre-clinical study 2Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 2Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 3Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 4Health News:Consistent exercise associated with lower risk of colon cancer death 2Health News:Consistent exercise associated with lower risk of colon cancer death 3Health News:Research Sheds Light on 'Starvation Hormone' 2Health News:How One Company Fought the Flu 2
(Date:12/22/2014)... 2014  Mark Farrah Associates (MFA), www.markfarrah.com ... of the 2015 marketplace exchange projections and insights ... According to a recent ASPE (Office of ... of Health and Human Services) report, an estimated ... plans through the Marketplace as of October 2014 ...
(Date:12/22/2014)... , Dec. 22, 2014  Pfenex Inc. (NYSE MKT: ... anthrax vaccine, has been filed and is now open ... by the Department of Health and Human Services (HHS), ... "We are extremely pleased to have the ... This represents a significant milestone in our company,s partnership ...
(Date:12/22/2014)... 2014 TWi Biotechnology, Inc., today announced ... AC-201, TWi Biotechnology,s lead drug candidate, from The ... for patent application numbered 201180018154.8.  This ... active metabolite for treatment of type II diabetes.  ... using AC-201 for type II diabetes, and provides ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3
... 15 This year,s American Friends of Rabin Medical ... to be an unforgettable evening. With Larry King ... being held on the historic Intrepid Sea, Air & Space ... be in attendance, including diplomats, civic, business, medical and philanthropic ...
... , EAST BRUNSWICK, N.J., Oct. 15 Savient Pharmaceuticals, ... of its previously announced underwritten public offering. Prior to ... purchase an additional 645,000 shares of common stock. As ... of its common stock at a price to the ...
Cached Medicine Technology:Larry King to Host 10th Annual American Friends of Rabin Medical Center 'Broadway on the Hudson' Gala 2Larry King to Host 10th Annual American Friends of Rabin Medical Center 'Broadway on the Hudson' Gala 3Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option 2
... a large body for increased stability ... centimeters center-to-center) to resist the wear ... indicators are molded into the body. ... bar electrode styles. Shielded bar electrodes ...
... Cadwell's custom bars have a ... solid, machined contacts (spaced 3 centimeters ... tear of repeated cleaning. Polarity indicators ... convenient, snap-on handle fits our bar ...
The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
... Evolutionary refractive lens technology for ... safety and efficacy, demonstrates quality of ... contact lens correction. The lens is ... and is now available for the ...
Medicine Products: